Phenazopyridine Hydrochloride

CHEMBL1201022 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
249.7 g/mol
LogP
Phase
4

A hydrochloride salt form of phenazopyridine with the same therapeutic properties. A urinary pain reliever that works directly in the bladder and urinary tract to reduce the burning, stinging, and discomfort caused by urinary tract infections or other irritation.

Молекулярная масса

249,7000 g/mol

TPSA

89,70 Ų

Терапевтические области

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.Nc1ccc(/N=N/c2ccccc2)c(N)n1

InChI

InChI=1S/C11H11N5.ClH/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8;/h1-7H,(H4,12,13,14);1H/b16-15+;

Molecular Formula

C11H12ClN5

HBD / HBA

3 / 5

Вращаемые Связи

2

Тяжёлые Атомы

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

A hydrochloride salt form of phenazopyridine with the same therapeutic properties. A urinary pain reliever that works directly in the bladder and urinary tract to reduce the burning, stinging, and discomfort caused by urinary tract infections or other irritation.

Yes, Phenazopyridine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201022. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 8691. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.